Vijayalakshmi Shanmugam

Gene expression profiling-based identification of cell-surface targets for developing multimeric ligands in pancreatic cancer

Robert J Gillies, Haiyong Han, Galen Hostetter, 2008, Molecular Cancer Therapeutics.

Germline mutations in HOXB13 and prostate-cancer risk.

J. Carpten, W. Tembe, D. Craig, 2012, The New England journal of medicine.

Whole genome sequencing reveals potential targets for therapy in patients with refractory KRASmutated metastatic colorectal cancer

Nicole A. Lavender, J. Carpten, G. Hostetter, 2014, BMC Medical Genomics.

Whole genome sequencing reveals potential targets for therapy in patients with refractory KRAS mutated metastatic colorectal cancer

Nicole A. Lavender, Winnie S. Liang, J. Carpten, 2014, BMC Medical Genomics.

Germline mutations in HOXB13 and prostate-cancer risk.

J. Carpten, K. Cooney, A. Ray, 2012, The New England journal of medicine.

Phase I Study of the Novel Surivin and cdc2/CDK1 Inhibitor Terameprocol in Patients with Advanced Leukemias.

J. Carpten, R. Tibes, K. McDonagh, 2009 .